Clinical Trial Update: CDK4/6 Inhibitor Intensification and Chemotherapy De-Escalation for Early-stage Luminal-HER2 Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating intensification of CDK4/6 inhibitor therapy with de-escalation of chemotherapy for early-stage luminal-HER2 breast ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CDK4/6 inhibitor

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 3 | Status: NOT_YET_RECRUITING